mGlu₅ negative allosteric modulators: a patent review (2010 – 2012)

By Emmitte Kyle A  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 4, 2013-04 ,pp. : 393-408

Informa Healthcare

Access to resources Recommend Favorite

mGluR2 positive allosteric modulators: a patent review (2009 – present)

By Trabanco Andrés A   Cid José María  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 629-647

Informa Healthcare

Access to resources Recommend Favorite

AMPA receptor positive allosteric modulators: a patent review

By Pirotte Bernard   Francotte Pierre   Goffin Eric   de Tullio Pascal  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 615-628

Informa Healthcare

Access to resources Recommend Favorite

Metabotropic glutamate receptor 4 (mGlu₄)-positive allosteric modulators for the treatment of Parkinson's disease: historical perspective and review of the patent literature

By Lindsley Craig W   Hopkins Corey R  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 461-481

Informa Healthcare

Access to resources Recommend Favorite

Ligands for the common allosteric site of acetylcholine M 2 -receptors: development and application

By Holzgrabe U.   Bender W.   Botero Cid H.M.   Staudt M.   Pick R.   Pfletschinger C.   Balatkova E.   Trankle C.   Mohr K.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 149-155

Elsevier

Access to resources Recommend Favorite